Cite
MLA Citation
Michael Wagner et al.. “795 A multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART).” Journal for immunotherapy of cancer, vol. 8, n.d., p. A475. http://access.bl.uk/ark:/81055/vdc_100144729984.0x000006